Advertisement

Topics

Latest "Texas Center for Proton Therapy" News Stories

08:38 EST 18th December 2018 | BioPortfolio

Here are the most relevant search results for "Texas Center for Proton Therapy" found in our extensive news archives from over 250 global news sources.

More Information about Texas Center for Proton Therapy on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Texas Center for Proton Therapy for you to read. Along with our medical data and news we also list Texas Center for Proton Therapy Clinical Trials, which are updated daily. BioPortfolio also has a large database of Texas Center for Proton Therapy Companies for you to search.

Showing "Texas Center Proton Therapy" News Articles 1–25 of 14,000+

Tuesday 18th December 2018

Cerus Completes CE Mark Submission for INTERCEPT Red Blood Cells

Cerus Corporation (Nasdaq:CERS) today announced that it has filed for CE Mark registration for the Company’s INTERCEPT red blood cell (RBC) system. “The INTERCEPT RBC CE Mark submission is a major milestone in the Company’s history and represents the culmination of years of effort to complete the full INTERCEPT portfolio of products to help ...


Multiverse Investment Fund Begins Operations in West Los Angeles

Company is Currently Invested in Twelve Companies in Various Areas of Bio and High Tech Multiverse Investment Fund I, LP (Multiverse) (http://www.multiverseinvestmentfund.com) a venture fund geared to investing in gatekeeper bio and high tech companies with potential for significant positive social impact and financial returns, has been launched in Wes...

Cala Health Streamlines Data and Operational Management for Neurological Device Study with Medidata Cloud

Study leverages Medidata Rave EDC, Edge eTMF and Edge Payments Cala Health unifies data and streamlines payments and document management on the Medidata Cloud Medidata supports observational study of first-in-class non-invasive, targeted nerve stimulator for the treatment of Essential Tremor The ...


HSTpathways Gains Momentum, Securing Top Ambulatory Surgery Centers to Improve Operational, Financial and Clinical Outcomes

Leading ASC Software Company Sees Increased Demand from Nation’s ASCs HSTpathways, the leading provider of cloud-based, ambulatory surgery center (ASC) management software in the U.S., today announced that over the past month, multiple health systems and some of the largest ASC organizations have selected the company to implement its software to achi...

Context Therapeutics Announces Key Additions to its Board of Directors

Philip Kantoff, MD, Chairman of the Department of Medicine at Memorial Sloan Kettering Cancer Center Elizabeth McKee Anderson, Seasoned Pharmaceutical Executive & Board Member Context Continues its Evolution into a Clinical-Stage Biopharmaceutical Company Context Therapeutics, a clinical-st...

Actuate Therapeutics Opens Phase 1 / 2 Clinical Study of 9-ING-41 in Patients with Refractory Cancers

Actuate advances best-in-class program into cutting edge clinical research study CHICAGO, IL and FORT WORTH, Texas (PRWEB) December 18, 2018 Actuate Therapeutics, Inc., a clinical stage biopharmaceutical company, today announced the enrollment of the first patients in its 1801 Phase 1 / 2 study of 9-ING-41, a proprietary glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in patients with refrac...

Drs. Richard Amato and Michael Kang Offer Dental Implants to Waterbury, CT, Combine Decades of Experience and Modern Technology

Dental implant specialists, Drs. Richard Amato and Michael Kang, welcome new patients in the Waterbury, CT area looking for a reliable tooth replacement solution to replace one or more missing teeth. This team of experienced periodontists is excited to offer advanced, precise techniques in modern dentistry to bring their patients optimal smile results with dental implants, the gold standard in too...

Loma Linda University Health's New Study Suggests Proton Therapy As a Better Option for Early-Stage Breast Cancer Patients

A new study by Loma Linda University Health suggests that partial breast proton therapy yields better quality of life results for patients after breast cancer surgery compared to whole breast irradiation. LOMA LINDA, Calif. (PRWEB) December 18, 2018 Patients with early stages of breast cancer who undergo partial breast proton irradiation treatment after a lumpectomy have better quality of life po...

Semma Therapeutics Expands Executive Leadership Team

-- Appoints David Lebwohl, M.D., as Chief Medical Officer, David DiGiusto, Ph.D., as Chief Technology Officer and Ann Darda as Head of Human Resources -- Semma Therapeutics, Inc., a biotechnology company pioneering the curative use of stem cells in regenerative medicine, today announced the appointments of David Lebwohl, M.D., as Chief Medical Officer ...

AmpliPhi Biosciences Successfully Optimizes Manufacturing Process and Scale Up for AB-SA01 Clinical Development

AmpliPhi’s wholly owned GMP facility now capable of producing material for over 100,000 doses from each drug substance batch of AB-SA01, sufficient to support clinical trial requirements AmpliPhi Biosciences Corporation (NYSE AMERICAN: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for patients ...

Baylor College of Medicine Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryBaylor College of Medicine BCM is a health science university that offers educational services. The university provides knowledge and applies science and discoveries to further education, healthcare and community services. It provides healthcare services through the integration of research, patient care, education and community services, among others. BCM offers training to medical, graduat...

University of Miami Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryUniversity of Miami is an educational institute that offers teaching and learning services to undergraduate and graduate students. The institute operates through its school of architecture, center for the humanities, school of law, college of engineering, miller school of medicine and center for Latin American studies. Its departments comprise sociology, psychology, physics, chemistry, biol...

Rice University Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryRice University is an educational service provider that provides graduate and undergraduate education programs and research services. The institute offers academic programs in the field of applied physics, cognitive sciences, computational science and engineering, environment, leadership, military science and naval science. It operates through various departments such as architecture, engin...

Gene Biotherapeutics Inc CRXM Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryGene Biotherapeutics Inc Gene Biotherapeutics, formerly known as Taxus Cardium Pharmaceuticals Group Inc, is a development stage company with focus on regenerative medicine. It develops manufacturing process and technology platforms for cardiovascular disease, wound healing and tissue engineering based on its core gene therapy. Its product portfolio includes FDA approved Excellagen topical ...

Cognate BioServices Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryCognate Bioservices Inc Cognate is a contract bioservices organization that provides development and cGMP manufacturing services. The organization provides services such as cGMP manufacturing, process development, cell therapy services and regulatory services. It offers commercial manufacturing and customized services. Cognate provides commercial manufacturing services through all stages of...

AmeriGroup Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryAMERIGROUP Corp Amerigroup a subsidiary of Anthem Inc is a managed health care service provider. The company provides services such as medicaid health care insurance program, children's health insurance program and longterm services and supports LTSS for lowincome seniors and people with disabilities. It offers medicare advantage plans which include prescriptions and overthecounter medicine...

Adventist Health System Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryAdventist Health System AHS is a faith based medical health care organization. The organization, through its technologies and clinical research provide general medical care and specialized care for more than four million patients every year. It serves through hospitals, nursing facilities and home care agencies. AHS provides various healthcare services such as cardiology center, diabetes, b...

OHSU Knight Cancer Institute Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryOHSU Knight Cancer Institute OHSU Knight, a subsidiary of Oregon Health Science University is a provider of various therapies for cancer treatments. The institute conducts clinical trials to develop therapies for cancer treatment, cancer prevention, diagnosis and screening. It offers medical therapy, surgical services, radiation therapy and other support services. OHSU Knight also offers a...

SUNY Upstate Medical University Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummarySUNY Upstate Medical University SUNY Upstate, a subsidiary of State University of New York is an academic medical center that provides education, biomedical research and health care services. The university's academic departments and programs include anesthesiology, emergency medicine, family medicine, medicine, neurology, neurosurgery, obstetrics and gynecology, among others. It offers pro...

CIncinnati Children's Hospital Medical Center Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryCincinnati Children's Hospital Medical Center CCHMC, a subsidiary of University of Cincinnati College of Medicine is a healthcare service provider that offers children care services. The center offers comprehensive clinical services and treatments for adaptive care, congenital heart disease, allergy and immunology, anesthesia, brain and spinal tumors, bone marrow transplantation, diabetes, ...

Centre National de la Recherche Scientifique Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryCentre National de la Recherche Scientifique CNRS is an educational center that provides research services. The center conducts interdisciplinary research in various domains, which include life and its social implications; information, communication and knowledge; environment, energy and sustainable development; nanosciences, nanotechnologies, materials; and astroparticles. It develops scie...

Idorsia's P2Y12 receptor antagonist - selatogrel - Phase 2 clinical studies meet their objective

Idorsia Pharmaceuticals Ltd. / Idorsia's P2Y12 receptor antagonist - selatogrel - Phase 2 clinical studies meet their objective . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Allschwil, Switzerland - December 18, 2018Idorsia Ltd (SIX: IDIA) today announced that Phase 2 clinical studies with selatogrel (...

STAT Plus: @Novartis is trying to prepare payers and policymakers for a forthcoming gene therapy that the company argues would be cost effective at $4 million to $5 million for each patient. https://buff.ly/2QyTROx 

STAT Plus: @Novartis is trying to prepare payers and policymakers for a forthcoming gene therapy that the company argues would be cost effective at $4 million to $5 million for each patient. https://buff.ly/2QyTROx 

Monday 17th December 2018

37 grupos de pacientes alzan la voz contra un reciente fallo judicial en el caso Texas v. EE. UU.

WASHINGTON, 17 de diciembre de 2018 /PRNewswire-HISPANIC PR WIRE/ -- Después del fallo judicial del viernes en el caso de Texas v. Estados Unidos, que Read more...

Crown Bioscience Creates Center of Excellence for Bioinformatics, Big Data, and Biomarker Discovery Services

Services and Capacity Increase with New Site Opening SAN DIEGO, Dec. 18, 2018 (GLOBE NEWSWIRE) — Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, has recently … Continue reading →


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks